Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+9.6%
5Y CAGR+10.0%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+9.6%/yr
vs +14.8%/yr prior
5Y CAGR
+10.0%/yr
Consistent
Acceleration
-5.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $526.83M | +10.6% |
| 2024 | $476.44M | +10.9% |
| 2023 | $429.68M | +7.5% |
| 2022 | $399.70M | +9.4% |
| 2021 | $365.50M | +11.9% |
| 2020 | $326.73M | +12.8% |
| 2019 | $289.60M | +25.7% |
| 2018 | $230.44M | +111.3% |
| 2017 | $109.05M | -8.2% |
| 2016 | $118.76M | - |